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Gas chromatography-mass spectrometric (GC-MS) methods for drug analysis routinely employ derivatising reagents. The aim
of this paper was to develop a method for the analysis of two recreational drugs, delta-9-tetrahydrocannabinol (Δ9-THC) and
cocaine in hair samples using GC-MS, without prior derivatisation, thus allowing the sample to be reanalysed in its original form.
An enzymatic digestion technique was also developed. Ten hair samples, that were known positive for either Δ9-THC and/or
cocaine, were enzymatically digested, extracted, and then analysed by GC-MS. All samples measured contained Δ9-THC and one
sample contained cocaine. The limits of detection (LOD) and quantification (LOQ) were 0.02 ng/mg and 0.05 ng/mg, respectively,
for cocaine and 0.015 ng/mg and 0.02 ng/mg, respectively, for Δ9-THC. The wide detection window, ease of direct analysis by GC-
MS, lower detection limits of underivatised samples, and the stability of drugs using this technique may oﬀer an improved method
of analysis.
1. Introduction
The United Nation’s Oﬃce on Drugs and Crimes (UNODC)
and the World Health Organisation (WHO) recently esti-
mated that 149–272 million people used psychoactive sub-
stances at least once in the past 12 months [1, 2]. The most
commonly used substance was cannabis (129–190 million
people), followed by amphetamine type stimulants, opioids,
and cocaine [1]. Cannabis and cocaine analyses by GC-
MS are two of the most frequently used drug assays [3, 4].
Research in analytical sciences has shown a sustained eﬀort to
develop methods with improved sensitivity and to facilitate
fast, reliable, and cost-eﬀective methods to identify users.
The specific reasons behind the need for detection range
from current risk to self and others, to future noncompliance
[5]. These individually lead to diﬀerent detection windows.
For example, authorities often require evidence of abstinence
from drugs before regranting driving licence [6, 7], allowing
child custody [8], returning to workplace [9, 10], or licensing
to practice [11]. In these cases, the detection window stretch-
es beyond the most recent consumption. The drug detection
window is one of the main analytical challenges, since most
drugs can only stay in our body system for shorts periods
for example, the plasma elimination half-life of tetrahy-
drocannabinol (THC) and THCCOOH is ca. 4.1 days and
5.2 ± 0.8 days, respectively, for frequent users [12]. Other
considerations include the accuracy, reproducibility, sample
quantity required, and limits of detection/quantification for
a developed method.
Drug analysis in hair has become a very common part
of forensic and clinical toxicology (doping, work-place drug
testing, rehabilitation programs, and treatment centres) [3,
13, 14]. Hair testing for drugs of abuse is a developing tech-
nique that oﬀers the possibility of a longer detection window
than is commonly obtained from urine or blood analysis
[15, 16] and thus distinguishes between long-term use and
short-term single exposure [17]. Hair testing improves drug
analysis by being noninvasive; samples are easy to store at
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room temperature and there is a negligible risk of infection.
Hair grows at ca. 1-2 cm each month [3]. Drugs incorporate
into hair through several mechanisms, either endogenously,
by ingestion (via the blood during hair formation or through
sweat and sebum), or exogenously, through external contam-
ination (deposition of drugs on the surface of the hair and
passive inhalation) [18]. Due to the extremely low incorpo-
ration rate of the psychoactive ingredient of cannabis, (Δ9-
THC), cocaine, and other drugs in hair (especially in blonde,
brown, and thin hair [19]), the development of sensitive
techniques is essential for quantitative analysis [14]. The con-
centration of the drug in hair may reflect the amount of
drug used; that is, if the rate of consumption is high or low.
In addition, when a sample shows the absence of drug, it does
not always mean that the sample is free from the drug, only
that the concentration may be too low to be detected. The
interpretation of hair analysis involves finding the correct
concentrations to distinguish between the common or occa-
sional consumer. Most methods include decontamination,
digestion, drug extraction, reconstitution, and derivatisation
for sample preparation preceding hair analysis by GC-MS
[16].
In this paper, we report lower limits of detection for Δ9-
THC and cocaine for the first time without derivatisation.
This is an improvement on previously reported methods that
achieved a lower limit of detection of 2.5 ng/mg for Δ9-THC
but with derivatisation [20]. Further method developments
in hair digestion and extraction have also been made, thus
permitting direct measurement of the drug without issues
such as contamination from reagents, formation of byprod-
ucts, and reduction in recovery, chromatographic resolution,
and ionisation eﬃciency that may arise from derivatisation.
2. Materials and Methods
2.1. Chemicals and Reagents. Delta-9-tetrahydrocannabinol
(Δ9-THC) and cocaine (1mg/mL) and their deuterated an-
alogues Δ9-THC-D3 and cocaine-D3 (100 µg/mL) were ob-
tained from LGC standards (Teddington, UK). Proteinase K
enzyme and HPLC grade pentane were obtained from Sigma
Aldrich (Dorset, UK), DTT Cleland’s reagent, and TRIS
HCl buﬀer were purchased from VWR, (Leicestershire, UK).
Hexane, dichloromethane, and all the other organic solvents
were HPLC grade from Fisher Ltd. (Leicestershire, UK).
2.2. Sample Preparation. Hair samples (50mg) were col-
lected from the posterior vertex [21, 22] (posterior cortex
hair rarely varies during growth and the hair number in this
area is more constant and less aﬀected by age and sex dif-
ferences [23]) and decontaminated by washing with 3mL
dichloromethane. They were vortex mixed for 2min (this
step repeated 3 times). This cleans the hair from contam-
inants such as colouring, sebum, shampoo, and so forth,
which may interfere with analysis. After decontamination,
the hair samples were pulverised to ca. 0.5mm long segments
by hand scissors. The samples were screened for the presence
of Δ9-THC or cocaine [21, 22].
For enzymatic digestion, the pulverized hair was added
to Proteinase K enzyme in a ratio of 1mg hair: 1mg enzyme;
followed by 100mg of DTT Cleland’s reagent and 1mL of
TRIS HCl buﬀer. The digestion was undertaken for 50min
at 37.5◦C, with continuous mixing. Hair was digested with
enzyme in the presence of Δ9-THC-D3 and cocaine-D3; a
spiked concentration of 1 ng/mg was used as internal stan-
dard. Drug-free hair was used as a control. A comparative
extraction was conducted using NaOH digestion of spiked
hair samples using 1mL of 1M NaOH at 95◦C for 10mins
followed by neutralisation with 1mL of 1M HCl and 3mL
of phosphate buﬀer (pH = 7, 0.2M).
The analytes were extracted by liquid-liquid extraction
(LLE) using 6mL of HPLC grade pentane. After vortex mix-
ing and centrifugation (10min at 2383 × g), the supernatant
organic layer was transferred into a fresh glass tube using
a Pasteur pipette and the hair residue pellet was discarded.
The organic layer was mixed with a 25 µL aliquot of 2M HCl
which had been diluted to 1% in phosphate buﬀer (pH = 7,
0.2M) to prevent drug loss during evaporation. The organic
layer was evaporated under a gentle stream of nitrogen gas
at 50◦C using a hotplate concentrator Techno DB-3 (Cam-
bridge, UK). Spiked samples of 0.02–1.50 ng/mg were pre-
pared for the Δ9-THC and cocaine calibration plots. The
extracted residue was reconstituted with 60 µL hexane, trans-
ferred to autosampler vials, and 3 µL was injected into the
GC-MS system.
2.3. Instrumentation. The extracts were analysed using an
AGILENT Technology 7890A gas chromatograph, in com-
bination with an AGILENT 5975 XL EI/CI MSD Triple
Axis Detector mass spectrometer connected to a 7683B
autosampler (Agilent Ltd., CA, USA) operating in electron
impact ionisation (EI) mode using Helium carrier gas with a
flow rate of 1.3mL/min. The analytical column for GC was
a BP-X5 SGE Forte Capillary column (Victoria, Australia)
(30m length × 0.25 µm film thickness × 0.25mm internal
diameter) (5% phenyl polysilphenylene-siloxane). Pulsed,
splitless injection was performed for a purge time of 1min,
a purge flow rate of 53mL/min, and an initial pulse pressure
of 20 PSI reducing to 15 PSI. This enhanced the peak shape
and sensitivity. The GC oven temperature for Δ9-THC was
programmed to start at 50◦C, held for 1min, then increased
to 200◦C at 40◦C/min, held for 2min, and increased to 280◦C
at 80◦C/min, held for 3min, to a final step of 310◦C at
80◦C/min, held for 4min.
For cocaine analysis, the initial temperature was 50◦C,
held for 1min, then increased to 200◦C at 100◦C/min, held
for 2min, then to 280◦C at 80◦C/min held for 3min, to a final
step of 310◦C at 80◦C/min, held for 4min. The injection port
temperature was set at 260◦C and the transfer line to 280◦C.
The quadrupole temperature was 150◦C; electron multiplier
voltage (EMV) 2,200V. The analysis was performed in select-
ed ion monitoring mode (SIM). The solvent delay time was
7min; elution window 7–13min. The precursor and product
ions of Δ9-THC, Δ9-THC-D3 internal standard (IS),cocaine,
and cocaine-D3 (IS) were, Δ9-THC, m/z 314, 299; Δ9-THC-
D3,m/z 317, 302 cocaine,m/z 303, 182; cocaine-D3,m/z 306,
185 (precursor ions, product ions). The retention times were






























































































































































Figure 1: GC-MS chromatogram and fragmentation pathway of Δ9-THC.
7.9min and 12.9min, respectively, for cocaine and Δ9-THC.
Between samples, at least one drug free sample was analysed
to monitor cross-contamination.
2.4. Validation. Blank hair (50mg) was spiked with solu-
tions of the analytes in methanol resulting in calibrator
concentrations of 0.02, 0.05, 0.1, 0.5, 1, and 1.5 ng/mg Δ9-
THC and cocaine and standard curves were linear with R2
values of 0.995 and 0.997, respectively. Calibration plots were
generated separately for Δ9-THC and cocaine. The lower
limit of detection (LLOD), lower limit of quantification
(LLOQ), intraday precision, interday precision, accuracy,
and recovery for each analyte were also calculated. Extraction
recovery was determined by comparing the area ratio of Δ9-
THC and cocaine extracted from 0.5 ng/mg spiked blank
hair samples with the area ratio of standard neat solutions
prepared in hexane of the same concentration. Cross-
contamination was tested by running diﬀerent blank hair
samples. No peaks were noted in the region of both drug’s
elution times.
3. Results and Discussion
3.1. Chromatographic Method. Linear calibration graphs
(Δ9-THC R2 = 0.995; cocaine 0.997) were established at con-
centrations ranging from 0.02–1.00 ng/mg for Δ9-THC and
0.05–1.00 ng/mg for cocaine. The calibration curves were
prepared by spiking known concentrations of Δ9-THC or
cocaine to blank hair samples at 0.02, 0.05, 0.10, 0.50, 1.00,
and 1.50 ng/mg, with a constant amount of Δ9-THC-D3 and
cocaine-D3 (1 ng/mg). The calculated peak area from GC
chromatograms for spiked concentrations was divided by the
peak of the internal standard to determine the abundance
ratio. The GC chromatograms (Figures 1 and 2) show peaks
representing Δ9-THC and cocaine eluting at Rt = 12.9± 0.2
and 7.9± 0.2mins, respectively.
3.2. Optimisation of the Procedure. Results shown in Figure 3
were obtained with the enzymatic and alkaline (NaOH) di-
gestions. For these tests, we intentionally used a blank hair
sample to reproduce true working conditions. Δ9-THC
(5 ng/mL) was spiked into two blank hair samples and





















































































































































































































































































Figure 3: Chromatogram obtained after spiking hair with 5 ng Δ9-THC and digesting it with (a) Proteinase K and (b) NaOH.
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Table 1: Summary of assay validation results.
Compounds
Recovery (%) at
0.5 ng/mg (N = 6)
Concentration
(ng/mg)
Precision RSD (%) Accuracy (%)
Intraday n = 6
per each
Interday n = 18
per each
Δ9-THC
0.02 15.4 18.0 114
0.10 15.6 7.0 110
102.2 0.50 8.0 5.0 95
Cocaine
0.05 12.1 10.6 98
0.10 10.1 12.1 101
96.5 0.50 5.1 2.8 110
Table 2: Hair analysis results of samples using GC-MS.
Hair samples Age Gender Δ9-THC ng/mg Cocaine ng/mg
SD SEM
n = 3
H1 22 F 0.08 ND ±0.006 0.003
H2 22 F 0.05 ND ±0.001 0.001
H3 18 F 0.35 ND ±0.006 0.003
H4 21 M 0.20 ND ±0.000 0.000
H5 24 M 0.18 ND ±0.017 0.010
H6 22 M 0.09 ND ±0.006 0.003
H7 20 M 0.08 ND ±0.010 0.006
H8 27 M 0.14 ND ±0.012 0.007
H9 18 M 0.13 ND ±0.006 0.003
H10 23 M 0.15 0.1 ±0.00/±0.015 0.000/0.009
ND: not detected, SD: standard deviation, SEM: standard error of mean.
digested with Proteinase K at 37◦C or by NaOH at a tem-
perature not greater than 95◦C. This process was repeated 6
times for each digestionmethod. Use of Proteinase K resulted
in an average concentration of 4.85 ng/mL ± 0.23 with 95%
recovery, whilst the samples digested by NaOH resulted in a
mean of 3.15 ng/mL ± 0.1 and 62% recovery.
One of the explanations for the reduced extraction
recovery when using NaOH is the drug degradation caused
by the strong basic NaOH conditions and high temperature.
This enzymatic hydrolysis method is an improvement over
other approaches, which could easily cause drug degradation
in the presence of sodium hydroxide (NaOH), hydrochloric
acid (HCl) and high temperatures, and thus improve the
stability of the method and therefore accuracy.
3.3. Method Validation. Validation results are shown in
Table 1. In the spiked hair samples, detection was feasible
for Δ9-THC concentrations as low as 0.015 ng/mg and for
cocaine at 0.02 ng/mg and quantification was possible at the
concentrations of 0.02 ng/mg and 0.05 ng/mg for Δ9-THC
and cocaine respectively using a signal to noise ratio >3.
3.4. Real Sample Analysis. All qualitatively identified posi-
tives (samples prescreened by ELISA; 9 positive for only Δ9-
THC and 1 positive for both Δ9-THC and cocaine) were
confirmed and quantified by GC-MS. Ten hair samples were
positive for Δ9-THC and one also for cocaine (Table 2).
Using the abundance ratio, the actual drug concentrations
(ng/mg) in the unknown hair samples ranged between 0.05–
0.35 ng/mg hair for Δ9-THC. The only positive sample for
cocaine was measured to be 0.1 ng/mg.
The number of publications describing analytical proce-
dures relating to drug incorporation into hair, decontami-
nation and analysis has increased in recent years [2, 23–26],
but in this paper an improved digestion and GC-MS method
has been proposed which enhances drug analysis capabilities.
The sensitivity achieved for Δ9-THC (LOD 0.01 ng/mg ±
0.01 and LOQ 0.02 ng/mg ± 0.01) and for cocaine (LOD
0.02 ng/mg± 0.015 & LOQ 0.05 ng/mg± 0.01) is better than
previous reports which have been obtained from derivatised
samples (LOD 0.025–2.5 ng/mg, LOQ 0.05–7.5 ng/mg for
Δ9-THC and LOD 0.03–0.5 ng/mg, LOQ 0.05–1 ng/mg for
cocaine) which is higher than what we achieved [20, 27–30].
Negative results could also mean that the concentration of
drug in hair is below the detection limit of the method. An
additional advantage of the increased sensitivity is that the
analysis required a reduced amount of hair, thus making the
method more feasible for drug testing [31].
Although derivatisation is an important factor to im-
prove sensitivity, it can be problematic in complex matrices.
Derivatisation is sometimes time consuming, can add possi-
ble contamination to the sample mixture, and could result in
a decrease in the sensitivity of the method. Also, derivatisa-
tion can create new interfering degradation product ions of
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the drug itself [32]. The performance in terms of reliability,
feasibility, and length of analysis can be improved by using
enzymes. In this study, GC-MS has been performed on
underivatised, informed positive hair samples for cocaine
and Δ9-THC. All the 10 samples in Table 2 were positively
confirmed (by ELISA) for Δ9-THC (10 samples) and 1 sam-
ple was found to be also positive for cocaine.
4. Conclusions
Hair analysis has proved to be a useful method of public
health research in the case of Δ9-THC and cocaine screening.
The method that has been developed is capable of detecting
exceptionally low levels of Δ9-THC and cocaine in human
hair when only ca. 50mg hair was processed. Enzymatic
digestion and the given chromatographic and mass spec-
trometric conditions were essential for reproducible and
accurate analysis of these psychotropic drugs in hair without
any interference. An additional advantage of this method is
that unlike previously published work, it does not require
derivatisation [17, 20, 23, 24]. Thus, it is a convenient and
potentially less problematic method which can be employed
for routine drugs testing. This method can complement
conventional blood and urine analysis with the advantages
of noninvasiveness of sample collection, negligible risk of
infection (blood analysis), facile sample storage (small sam-
ple size, limited biohazard and adulteration/contamination
risks), and negligible sample degradation. Also, hair analysis
could help prevent false negative ELISA results that can
be encountered from the higher limit of detection or
even previously developed GC-MS methods by detecting
ultra-low concentrations. The limit of detection for ELISA
screening was found to be 0.5 ng/mg for the cocaine kit and
0.3 ng/mg for Δ9-THC. These were used as cut-oﬀ levels for
screening of the hair samples.
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